Stay updated on Inotuzumab Post-Transplant for ALL Clinical Trial

Sign up to get notified when there's something new on the Inotuzumab Post-Transplant for ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inotuzumab Post-Transplant for ALL Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Footer changes show a new Revision: v3.3.3; the HHS Vulnerability Disclosure link and the older Revision: v3.3.2 have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:26:44.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The history now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T17:59:36.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removed an administrative notice about government funding/operating status; this does not affect trial data or the history content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T17:51:46.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Version 23 was added to the Record History on 2025-06-02, updating the study status and related details.
    Difference
    0.1%
    Check dated 2025-11-03T12:36:09.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Updated to v3.2.0 and added a government funding/operating-status notice; removed the old v3.1.0 reference.
    Difference
    11%
    Check dated 2025-10-05T16:45:46.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T09:51:31.000Z thumbnail image

Stay in the know with updates to Inotuzumab Post-Transplant for ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inotuzumab Post-Transplant for ALL Clinical Trial page.